The German Arzneimittelpreisverordnung – AMPreisV determins prices and price .. Legal basis are FMD /62/EU (Falsified Medicines Directive) and the. Arzneimittelpreisverordnung Mortality and health indicators, – ( selected years). 10 Health care workforce per population, – Umsatzentwicklung des Apothekenmarktes seit Mittel (hier: H.v. pharmazeutischen Erzeugnissen) , , , Arzneimittelpreisverordnung).

Author: Sagis Dolar
Country: Laos
Language: English (Spanish)
Genre: Career
Published (Last): 9 April 2018
Pages: 105
PDF File Size: 3.36 Mb
ePub File Size: 14.8 Mb
ISBN: 765-7-76035-941-4
Downloads: 62566
Price: Free* [*Free Regsitration Required]
Uploader: Tygosida

Revocation of consent means that further participation of the subject in the clinical study is prohibited and no further data can be collected. Reinforcing the rules on clinical evidence, including an EU-wide co-ordinated procedure for authorising multi-centre clinical investigations.

A marketing authorisation is issued on a national basis in each concerned member state. Combination products Many current innovative products are combination products consisting of, if stand-alone, a medical device and a medicinal product. How can a product liability claim be brought? An exception is the parallel distribution of centrally authorised medicinal products.

Arzneimittel-Festbeträge – GKV-Spitzenverband

Period of authorisation and renewals The competent authorities usually grant unlimited authorisations. Packaging and labelling The substantive requirements for the application documents are set out in sections 22 to 24 of the Medicinal Products Act and the Code for Human Medicines Directive.

A pharmaceutical entrepreneur’s liability to compensate only exists if either:. The FSA Code of Conduct on Collaboration with Health care Professionals, last amended on 15 Novemberis the largest voluntary self-regulation of the pharmaceutical industry. The following must be submitted in relation to the medical product:.

ABDATA, Pharma-Daten-Service

Further labelling regulations must also be observed, in particular the Narcotic Drugs Act see arzneimittelpreisverlrdnung When used in accordance with its intended purpose, the medicinal product has harmful effects that exceed the limits considered tolerable in the light of current medical knowledge. Mandatory safety features a unique identifier and anti-tampering device on the outer packaging.

Pharmacies and wholesalers charge surcharges on the manufacturers’ selling prices. Such products must comply with the EMA notification procedure for parallel distribution. Medicinal arzenimittelpreisverordnung must generally be available in pharmacies only, even though statutory health insurance fund companies can reimburse the costs of over-the-counter medicinal products OTCs.


There are strict reporting requirements for both the competent authority and the sponsor in section 12 et seq.

According arzneimittelpreisverordnujg the Medicinal Products Act, there are maximum amounts of liability:. Recently, the Federal Ministry of Health announced that it aims to draft a second e-Health law in the current legislative period starting In Germany, there are several regulations and industry codes dealing with different aspects of compliance. The consent is only valid if the subject is capable of acting and able to understand the nature and meaning of the consent.

Most medical care is now provided with reference-price medicinal products. Often, combination products are medical devices that have been coated or impregnated with a drug substance, for example, antimicrobial coated catheters or stent coated with a special drug. It introduces an authorisation procedure based on a single submission through an EU portal, an assessment procedure leading to a single decision, rules on protecting subjects and informed consent, and transparency requirements.


The same legal requirements apply for mail order pharmacies as for any retail pharmacy. The competent authorities issue necessary directives to rectify any identified infringements and prevent future infringements section 69 1Medicinal Products Act. A national marketing authorisation, issued through the national procedure by the Federal Institute for Drugs and Medical Devices or the Paul-Ehrlich-Institute, depending on the product. The competent authorities must issue directives to rectify any offences that have been identified and prevent offences in the future section 69, Medicinal Products Act.

All medicinal products to be reimbursed must be registered in the Lauer-Taxe.

English arzneimitttelpreisverordnung are arzneimittelpreisverordning available, for guidance only. This is particularly the case if the medicinal product is not available on prescription, intended to treat a minor ailment or can be classified as a lifestyle medicinal product. After inclusion in the Lauer-Taxe, the medicinal product receives a central pharmaceutical number PZNa national identification key for products distributed by pharmacies.


Legislation and regulatory authority Title V of the Code for Human Medicines Directive, regulating the labelling of medicinal products for human use and package leaflets, has been implemented in the Medicinal Products Act at sections 10 to Also Found In Patents Product liability and safety. Parallel imports normally occur where a third company, independent of the marketing authorisation holder or manufacturer, acquires medicinal products in another EU or EEA member state and imports them into Germany.

In Germany, a large number of preparations of comparable quality, with comparable effect and partly identical composition, are available at very different prices.

ABDATA, Pharma-Daten-Service [WorldCat Identities]

Monitoring compliance and penalties Section 30 of the Medicinal Products Act contains special provisions on the general arzmeimittelpreisverordnung of the Administrative Procedure Act Verwaltungsverfahrensgesetz VwVfGwhich regulates the revocation and withdrawal of administrative acts. Consent can be revoked.

They vary between the federal states and are fixed on a case-by-case basis. This includes the supply of medicinal products. What is the authorisation process for manufacturing medicinal products? Intellectual property patents, trade marks, unfair competition ; life sciences medicinal products, medical devices. Advising a medical device company on regulatory and data protection compliance for its mobile health apps.

The processing of personal data, including data concerning health, for mere scientific purposes may be permitted without consent in certain limited scenarios.

It has araneimittelpreisverordnung established to safeguard necessary collaboration between the pharmaceutical industry and all health care professionals, and to ensure compliance with the legal conditions for such collaboration.

Any such liability requires a breach of a duty of care Verkehrspflicht. Outline the regulation of clinical trials. There is sufficient reason to suspect that the medicinal product has harmful effects exceeding.